Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on February 5, 2009, regarding events occurring on February 2, 2009. The filing details the closing of a public debt offering.
Key Financial Metrics
- Debt Issuance: The Company sold $1.0 billion in aggregate principal amount of senior notes.
- 2014 Notes: $400 million principal amount, 6.000% interest rate, maturing February 15, 2014.
- 2019 Notes: $600 million principal amount, 7.000% interest rate, maturing February 15, 2019.
- Net Proceeds: Approximately $990.3 million after deducting underwriting discounts and offering expenses.
- Interest Payments: Payable semi-annually on February 15 and August 15, commencing August 15, 2009.
Material Changes and Use of Proceeds
The primary material change is the creation of a direct financial obligation totaling $1.0 billion. The Company intends to use the net proceeds for working capital and general corporate purposes, specifically including the repayment of short-term debt and the repurchasing of common stock. The Indenture governing these notes does not prohibit or limit the incurrence of additional indebtedness.
Terms, Risks, and Contingencies
- Redemption: The Company may redeem the notes at its option at a price equal to the greater of 100% of the principal amount or the present value of remaining payments discounted at the treasury rate plus 50 basis points.
- Change of Control: If a change of control occurs and the notes are downgraded below investment grade by Moody's, S&P, and Fitch, the Company must offer to repurchase the notes at 101% of the principal amount plus accrued interest.
- Events of Default: Include failure to pay principal or interest, breach of indenture terms for 60 days, or bankruptcy/insolvency proceedings.
- Underwriters: Banc of America Securities LLC and Deutsche Bank Securities Inc. acted as representatives. Affiliates of the underwriters are participants in the Company's revolving credit agreement.
Investor Verification Checklist
- Verify the exact amount of short-term debt repaid and shares repurchased using the $990.3 million in net proceeds.
- Review the "Ratio of Earnings to Fixed Charges" computation attached as Exhibit 12.1 to assess debt service coverage.
- Confirm the Company's current credit ratings with Moody's, S&P, and Fitch to evaluate the risk of the change-of-control repurchase provision.
- Examine the Underwriting Agreement (Exhibit 1.1) and Indenture (Exhibit 4.1) for specific covenants not detailed in this summary.